Advertisements

Florfenikel

Quick links to important sections

Florfenikel

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Florfenikel

Property Description
Active ingredient Florfenicol (INN)
Form Injectable solution, Oral solution, Soluble Powder
Pharmacological class Antibiotic (Amphenicol class)
Common purpose Anti-infective agent for bacterial diseases
Origin Synthetic (Fluorinated derivative)

1. Florfenicol: Definition, Origin, and Unique Structure

Florfenikel is the trade designation for the active substance Florfenicol, which is classified as a synthetic broad-spectrum antibiotic belonging to the amphenicol class of antimicrobials. The drug is a unique fluorinated derivative of thiamphenicol. This specific structural modification is critical because it grants the drug an important advantage: resistance to inactivation by enzymes that typically degrade older antibiotics in this class, such as chloramphenicol. This feature is why Florfenicol remains effective against certain resistant pathogens.

2. Differentiating Features and Pharmaceutical Forms

Florfenicol is strictly reserved for use in veterinary medicine as a prescription-only (Rx) animal drug, a key differentiating feature from similar compounds. It is manufactured under various global brands for therapeutic use in livestock and aquaculture. The preparations are primarily single-active-ingredient products available as injectable solution (for parenteral use), oral solution, and oral soluble powder. Its stability in solution forms, such as the injectable, relies on specific organic solvent systems due to the compound’s low water solubility.

3. General Therapeutic Purpose

Florfenicol functions as a bacteriostatic anti-infective agent. Its general therapeutic purpose is to control and resolve diseases caused by susceptible bacterial pathogens by halting their growth and spread. The mechanism involves blocking the bacteria's ability to produce essential proteins by binding to the 50S ribosomal subunit. This action arrests the infection's progression and supports the host organism's natural defenses in achieving bacterial clearance. Its clinical recognition is high for treating bacterial infections in farm animals.

Regulatory References

  1. Florfenicol Mechanism of Action (NIH/PMC)
Advertisements

What side effects are possible with Florfenikel?

Possible Side Effects and Safety Information

The safety profile for Florfenicol is based on classifications documented in official regulatory sources, such as the Summary of Product Characteristics (SmPC) and FDA labeling. Adverse reactions are grouped by frequency and the physiological systems affected.

Frequency and System-Organ Classifications

The most frequently observed adverse reactions are classified as Very Common. These effects primarily involve the gastrointestinal system and the site of administration.

System-Organ Class Very Common Adverse Reactions
Gastrointestinal Disorders Transient diarrhea or softening of faeces, decreased food and water consumption, transient lethargy
General & Administration Site Conditions Local reactions at the injection site (e.g., swelling, induration, heat, pain)

Most gastrointestinal and general systemic effects, such as lethargy, are typically described as transient. However, official documents note that localized tissue reaction at the injection site may persist for several weeks following administration.

Specific Safety Constraints

Official labeling includes specific restrictions related to certain populations. Florfenicol is not recommended for use in breeding animals due to safety concerns regarding the male reproductive system observed in laboratory studies. Furthermore, the use of Florfenicol is restricted in very young/juvenile animals, such as calves less than four weeks old, pending sufficient safety data. Restrictions are also noted regarding co-administration with other drug classes, including non-steroidal anti-inflammatory drugs (NSAIDs) and anticoagulants.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Florfenicol overdose is based on dose-dependent findings observed in target animal species following high-multiple exposure. This information details specific clinical manifestations and the required actions for seeking professional assistance.


Overdose Scope

Feature Official Regulatory Statement
Documented Manifestations Diarrhoea, vomiting, reduced food and water intake, and indicators of dehydration.
Exposure-Related Factors Administration of three times the recommended dose or more; repeated weekly administration of high multiples of the dose.
Population-Specific Notes Pre-ruminant calves demonstrated increased susceptibility, with repeated high-dose exposure leading to severe adverse effects, including death.

Emergency Response

Feature Official Regulatory Statement
Antidote Status No specific antidote is documented or known.
Required Action Immediate expert professional attention is required upon the onset of severe clinical signs or suspicion of high-multiple dose exposure due to documented fatalities.

Connection to the Overall Overdose Profile

The official overdose statements confirm that high-dose exposure can result in severe outcomes, including fatality and macroscopic intestinal lesions, such as abomasal ulcers. This regulatory profile establishes the severity of risk and dictates that expert professional assistance must be sought immediately following a suspected overdose, particularly in susceptible young animals, due to the lack of a known antidote.

Advertisements

Therapeutic Uses of Florfenikel

What Florfenicol Treats: Main Uses and Benefits

Florfenicol is a targeted anti-infective agent generally used to help manage severe bacterial diseases in livestock and aquaculture. Its use is considered relevant in clinical settings marked by acute episodes associated with increased clinical risk.

The medication is considered relevant for managing diseases that fall into three main therapeutic domains. It is applied across conditions that present with systemic or localized discomfort, including Bovine Respiratory Disease (BRD), Porcine Respiratory Disease Complex, Acute Interdigital Necrobacillosis (Foot Rot), and septicemia in fish.


Key Therapeutic Contexts

Florfenicol is commonly used when short-term symptomatic assistance is needed, such as during phases when bacterial infections become more noticeable and disruptive. This approach is relevant for helping to ease symptoms that interfere with daily functioning, like pronounced labored breathing or acute lameness.

The medication plays a role in managing the infection, which supports the animal during difficult episodes by easing distress. It is applied across domains where additional symptomatic support is needed, managing serious, complex infections.

Quick Fact: Supportive Management for Respiratory and Systemic Discomfort


Primary Benefits

The medication helps address symptom clusters that may become intense or disruptive, such as those related to systemic imbalance and physiological strain. By assisting with managing the infection, it contributes to easing the overall symptom load and supports the animal during acute episodes, supports the maintenance of functional stability.

Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Florfenikel — Official Regulatory Information

Category Regulatory Status
Populations Allowed Beef and non-lactating dairy cattle; Swine for control of Swine Respiratory Disease; Catfish and freshwater-reared salmonids for specific mortality control.
Contraindicated Animals with known hypersensitivity to the medicine; Adult bulls, rams, or boars intended for breeding purposes; Animals to be processed for veal.
Age-Related Exclusion Not for use in female dairy cattle 20 months of age or older; Not recommended for calves less than 4 weeks old (due to lack of safety data).
Organ Function Restriction Contraindicated in animals suffering from impaired hepatic, cardiac, or renal function; Avoid use in severely dehydrated or hypotensive animals.
Reproductive Status Not authorised for use in lactating animals producing milk for human consumption; Safety regarding reproductive performance, pregnancy, and lactation is not determined in breeding stock.

Connection to the overall eligibility profile: Regulatory documents structure the eligibility for Florfenicol by establishing clear limitations based on the animal’s life stage, intended production use, and pre-existing health status. Absolute exclusions apply to breeding stock and populations that could result in drug residues in the human food supply (e.g., veal calves, lactating dairy cows). Eligibility is further restricted by formal contraindications for animals with existing major organ dysfunction, as explicitly stated in the official regulatory labeling.

Advertisements

What should I know about interactions with other medicines?

The official regulatory profile for Florfenikol strictly documents several interaction patterns, primarily categorized as contraindicated combinations and those that alter drug exposure.

Prohibited Combinations and Pharmacodynamic Interference

The product label specifies several drug classes that are prohibited for co-administration due to interaction risks. These restrictions include combination with other antibiotics, based on the potential for antagonistic pharmacodynamic effects. Co-administration is also formally prohibited with indirect anticoagulants, certain barbiturates, and muscle relaxants due to the risk of reinforced systemic activity.

Exposure-Altering Interactions and Procedural Constraints

An important pharmacokinetic pattern is the interaction with Doxycycline, which is documented to slow down Florfenikol's metabolism through the inhibition of the Cytochrome P450 3A (CYP3A) enzyme system. This interaction results in increased Florfenikol tissue concentrations, which requires a regulatory measure: the extension of the official withdrawal period to manage food residue risk. Procedural constraints also exist, advising against administering the medicine in close proximity to vaccination to prevent interference with the immune response. Furthermore, official data notes that oral absorption of the medicine may decrease when administered with milk replacers.

Advertisements

Mechanism of Action

Direct Inhibition of Bacterial Protein Synthesis

Florfenicol acts by selectively binding to the 50S ribosomal subunit within the target bacteria, physically obstructing the peptidyl transferase enzyme. This critical molecular interference halts the process of protein elongation, which is required for the synthesis of bacterial proteins, leading to a bacteriostatic effect that suppresses cell multiplication.


Targeted Interference with Growth Cascade

The primary mechanism initiates a cascade where the prevention of peptide bond formation starves the bacteria of necessary structural and enzymatic proteins. This disruption of the core anabolic pathway prevents the bacteria from replicating their cellular machinery and contributes to the modulation of bacterial growth rate within the host system.


Structural Resistance to Inactivation Mechanisms

A key mechanistic domain is Florfenicol's structural design, which incorporates a fluorine atom that makes it inherently resistant to common bacterial acetyltransferase enzymes. This crucial modification allows the active molecule to bypass a major bacterial detoxification pathway, resulting in the maintenance of the molecule's inhibitory activity against the ribosome, thereby retaining the molecule's ability to inhibit protein synthesis across certain bacterial phenotypes.

Advertisements

Dosage and Administration Information

Florfenicol is administered via different routes and standardized dosage forms depending on the target species. The primary forms include an injectable solution (300 mg/mL) for parenteral use in cattle and swine, and oral preparations (concentrates or medicated feed articles) for aquatic species and swine.

Administration routes are specific to the target species and preparation. For cattle, the injection is given either intramuscularly (IM) as a two-dose regimen or subcutaneously (SC) as a single, higher-dose regimen. Oral use involves mixing the active ingredient into the animal’s drinking water or feed, which must then be administered as the sole ration for the course duration.

Dosing and Scheduling

Dosing is based on body weight (mg/kg) to ensure precise administration.

Species Route Dose Rate Frequency
Cattle (IM) 20 mg/kg Twice, 48 hours apart
Cattle (SC) 40 mg/kg Single dose
Swine (IM) 15 mg/kg Twice, 48 hours apart
Finfish (Oral Feed) 10-15 mg/kg/day Daily for 10 consecutive days

Procedural Constraints

Specific procedures apply to the administration. For injections, the maximum volume administered at any one site must not exceed 10 mL in cattle or 3 mL in swine. The injection should be given only in the neck area. Furthermore, use is restricted in specific groups, such as female dairy cattle 20 months of age or older and adult bulls intended for breeding purposes.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Florfenikel

This section summarizes the official research record that supports the regulatory approval of Florfenikel, focusing on the types of studies that exist and what outcomes were measured.

Evidence for Use in Bovine Respiratory Disease (BRD) and Porcine Respiratory Disease Complex (PRDC)

The primary research for its use in cattle and swine involves controlled clinical field trials and experimental challenge studies. These studies examine measurements of physiological changes, such as fever and respiratory signs in cattle, and monitor outcomes related to symptom intensity and changes in lung pathology in swine. Research also explored impacts on production parameters, including weight gain. Findings describe patterns observed in the evolution of symptoms in groups that received the medicine.

Evidence for Use in Bacterial Septicemia in Aquaculture

The research base supporting use in fish involves dose-titration and controlled challenge studies conducted across various cultivated species. Research examined primary outcomes related to survival rates (cumulative mortality) and the progression of infection. Detailed pharmacokinetic studies were also conducted, tracking the medicine's concentration and persistence within different tissues.

Research Limitations and Uncertainty

Evidence highlights what is known—and what is still uncertain. Many trials involve combination therapies, which means certainty remains low about the precise, singular contribution of Florfenikel. The typical follow-up durations were short, and the available research provides limited information for long-term outcomes such such as sustained change in monitored outcomes. Research is ongoing concerning how the medicine's presence in the gut may contribute to the selection of antimicrobial resistance patterns.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Florfenikel (FAQ)

Q: Are there any long-term side effects associated with Florfenikel use?

A: Official regulatory toxicity studies, primarily conducted on laboratory animals, have been used to establish safety guidelines. These studies have reported effects on the male reproductive system and changes in organ weights following prolonged exposure. These findings are the basis for the official restriction against using Florfenikel in breeding animals.

Q: Can Florfenikel cause a reaction if the animal is allergic to other medicines?

A: Official product information states that Florfenicol is contraindicated (should not be used) in animals with a known hypersensitivity or allergy to the drug itself. The regulatory documents do not provide explicit guidance on potential cross-reactions or allergies related to other distinct medications.

Q: Does Florfenikel affect the gut flora of the treated animal?

A: Regulatory documents and general information indicate that, as a broad-spectrum antibiotic, Florfenicol can affect the microbial population (gut flora) in the treated animal. Regulatory agencies account for this potential impact when establishing safe limits for drug residue in food animals.

Q: How long does Florfenikel stay in the animal's system?

A: The concentration and persistence of Florfenicol in an animal's tissues depends on the species and the route of administration. Elimination primarily occurs via the kidneys. For food-producing animals, regulatory documents define a mandatory withdrawal period, which is the required time for the drug to safely clear the animal's system before it can be processed for food.

Q: What are the signs that Florfenikel is working to treat an infection?

A: The drug label expects clinical improvement to be evident in most treated subjects within 24 hours of starting treatment for conditions like Bovine Respiratory Disease (BRD). Regulatory guidelines state that if a positive response is not noted within 72 hours, the diagnosis should be re-evaluated by a veterinarian.

Q: Does giving Florfenikel affect an animal's future fertility?

A: Official regulatory information clearly restricts the use of Florfenicol in animals intended for breeding purposes, such as adult bulls, rams, or boars. The effects of the drug on the reproductive performance of breeding animals have not been fully determined according to the product label.

Q: What kind of bacteria is Florfenikel most effective against?

A: Florfenicol is indicated for diseases caused by specific susceptible bacteria as listed in the product documents. Examples include organisms that cause respiratory diseases, such as Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni, as well as specific bacteria causing septicemia in fish.

Q: How is Florfenikel excreted from the body?

A: Official pharmacokinetic studies, which track how the drug moves through the body, indicate that Florfenicol is primarily eliminated from the animal's system via urinary excretion (through the kidneys).

Q: Is there any research on the development of bacterial resistance to Florfenikel?

A: Yes, regulatory contexts acknowledge research into the drug's effectiveness. Florfenicol has a unique molecular structure that helps it maintain its activity against certain bacteria that have become resistant to older related antibiotics. Monitoring for resistance development is an ongoing area of regulatory research.

Q: What is the typical duration of a Florfenikel treatment course?

A: The length of the treatment course is determined by the specific administration protocol for the target species. For example, some treatments involve a two-dose regimen given 48 hours apart, while oral treatment in fish often spans 10 consecutive days.

Q: Are there specific breeds of animals that should not receive Florfenikel?

A: The restrictions for Florfenicol use are based on the animal's species, age, and production status (e.g., adult bulls, female dairy cattle, young calves), rather than specific breeds. The product label does not list exclusions based on breed.

Q: Can Florfenikel be used in fish farming or aquaculture?

A: Yes, Florfenicol is authorized for use in aquaculture in certain jurisdictions. It is indicated for use in specific fish species, such as catfish and freshwater-reared salmonids, to control mortality caused by certain bacterial diseases.

Q: Does Florfenikel affect liver or kidney function in healthy animals?

A: Regulatory documents primarily focus on contraindicating use in animals that already have impaired liver or kidney function. Toxicity studies on laboratory animals have reported some changes, such as increased liver weights, generally observed in high-dose and long-term exposure scenarios.

Q: Is it common for Florfenikel to be combined with other drugs in a single product?

A: Florfenicol is manufactured and sold as a single-active-ingredient product and also in combination products. These combination products are formulated to contain another active ingredient, such as an anti-inflammatory drug, for enhanced therapeutic effect.

Q: Can Florfenikel be used in young, newborn animals?

A: Florfenicol is not recommended for use in very young animals, specifically calves under four weeks old. This restriction is due to a lack of sufficient safety data for this particular age group, as noted in the product's safety constraints.

Q: Are there any reported studies on the human health risk of Florfenikel residue?

A: Yes, regulatory agencies establish strict standards to protect public health. They conduct toxicological reviews to set an Acceptable Daily Intake (ADI) for humans, which is then used to establish Maximum Residue Limits (MRLs) in edible animal tissues.

Q: Are there any specific safety precautions veterinarians take when administering Florfenikel?

A: Yes, official administration guidelines mandate specific procedural constraints. These include limiting the maximum volume of the injection (e.g., 10 mL in cattle) given at any one site and specifying that the injection must be administered only in the neck area.

Advertisements

How should Florfenikel be stored and disposed of?

How to Store and Dispose of Florfenicol

Official regulatory documents mandate strict conditions for the storage and disposal of Florfenicol to maintain stability and protect the environment.


Storage Requirements

Condition Regulatory Mandate
Temperature Store at or below 25 C (77 F). Do not freeze injectable solutions.
Protection Keep in the original container, tightly closed, and protect from light and moisture.
Stability The product has a limited in-use shelf-life (e.g., 28 days) after the container is first opened.
Security Store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Florfenicol and its containers must not be disposed of via wastewater or household waste due to the potential for environmental contamination. The product must be managed as pharmaceutical waste and discarded in accordance with local regulatory requirements to prevent release into surface waters or ditches.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Florfenikel found in:

A-Z Index: